Tony Bark@pawb.social to science@lemmy.worldEnglish · edit-22 days agoScientists discover how to reactivate cancer’s molecular “kill switch” at the Jackson Laboratorywww.jax.orgexternal-linkmessage-square7fedilinkarrow-up1138arrow-down13cross-posted to: science@lemmit.online
arrow-up1135arrow-down1external-linkScientists discover how to reactivate cancer’s molecular “kill switch” at the Jackson Laboratorywww.jax.orgTony Bark@pawb.social to science@lemmy.worldEnglish · edit-22 days agomessage-square7fedilinkcross-posted to: science@lemmit.online
minus-squareMaeve@kbin.earthlinkfedilinkarrow-up16·2 days agoWill it be accessible to everyone? I read it. Just musing.
minus-squareDharma Curious (he/him)@slrpnk.netlinkfedilinkEnglisharrow-up6·2 days agoProbably not in the US, but hopefully it’ll at least be accessible for the insured…
minus-squareearphone843@sh.itjust.workslinkfedilinkEnglisharrow-up4·2 days agoIt really depends on if production can scale.
minus-squareTony Bark@pawb.socialOPlinkfedilinkEnglisharrow-up2·2 days agoI hope so. It is RNA-based.
minus-squareGentriFriedRice@lemmy.worldlinkfedilinkEnglisharrow-up3·1 day agoWell the RNA bit is the easy part. Finding a way to target cancer cells with gene splicing gets trickier
Will it be accessible to everyone? I read it. Just musing.
Only for the good guys
Probably not in the US, but hopefully it’ll at least be accessible for the insured…
It really depends on if production can scale.
I hope so. It is RNA-based.
Well the RNA bit is the easy part. Finding a way to target cancer cells with gene splicing gets trickier